Sericin’s Potential in Osteoporosis Management: The Roles of L-Serine and D-Serine in Bone Metabolism Regulation
Nutrients · 2025
DOI: 10.3390/nu17030574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Jwa-Young Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Hallym University Kangnam Sacred Heart Hospital, Hallym University Medical Center, 1 Singil-ro, Yeongde…. Hauptthemen laut MEDLINE: Sericins, Osteoporosis, Serine, Bone and Bones. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rural Development of Administration, Republic of Korea, Rural Development Administration, Republic of Korea.
Abstract (Originalsprache)
Background
Osteoporosis is a bone remodeling disease characterized by an imbalance between bone formation and resorption, leading to bone fragility. Current treatments focus on bone resorption suppression but often have adverse effects. This study aimed to explore the potential of sericin, a silkworm-derived protein, as a dual-action therapeutic agent that enhances bone formation through its component L-serine and inhibits bone resorption via D-serine, which is derived from L-serine by the action of serine racemase.
Methods
Cellular experiments were conducted to evaluate the effects of L-serine on osteoblast differentiation and D-serine on osteoclast inhibition. Serum levels of D-serine were measured following sericin administration in an osteoporosis animal model. μ-CT analysis assessed trabecular and cortical bone quality, and bone-related protein expression was analyzed using immunoprecipitation-based high-performance liquid chromatography (IP-HPLC).
Results
L-serine significantly upregulated osteogenic markers, including alkaline phosphatase (ALP), Runx2, osterix, and Col1a1, in osteoblasts (p < 0.05). D-serine inhibited osteoclast activation by suppressing cathepsin K expression (p < 0.001). Sericin feeding elevated serum D-serine levels (p < 0.001) and upregulated bone-related proteins such as BMP-2, osterix, and Runx2. Micro-computed tomography (μ-CT) analysis revealed significant improvements in trabecular bone parameters in the OVX-sericin group, including increased trabecular bone volume (Tb.BV/TV; p < 0.05) and reduced trabecular separation (Tb.Sp; p < 0.05), compared to the OVX and OVX-amino acid groups. Cortical bone parameters, including cortical bone volume (Ct.BV/TV) and cortical area (Ct.Ar), did not significantly differ among OVX groups, but all were lower than in the sham group (p < 0.05).
Conclusions
This study demonstrates that sericin modulates bone metabolism by enhancing osteoblast activity through L-serine and inhibiting osteoclastogenesis via D-serine. Sericin supplementation improved trabecular bone mass in an osteoporosis model, highlighting its potential for bone health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Hallym University Kangnam Sacred Heart Hospital, Hallym University Medical Center, 1 Singil-ro, Yeongdeungpo-gu, Seoul 07441, Republic of Korea.
- Department of Biochemistry and Cell Biology, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
- Department of Oral Pathology, College of Dentistry, Gangneung-Wonju National University, 7 Jukheon-gil, Gangneung-si 25457, Gangwon-do, Republic of Korea.
- Industrial Insect and Sericulture Division, National Institute of Agricultural Science, Rural Development Administration, Wanju 55365, Republic of Korea.
- Institution of Hydrogen Magnetic Reaction Gene Regulation, Daejeon 34140, Republic of Korea.
- Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University, 7 Jukheon-gil, Gangneung-si 25457, Republic of Korea.
ORCID-Profile: Jwa-Young Kim, Xiangguo Che, Jongho Choi, Joon Ha Lee, Ji-Hae Lee, Suk Keun Lee, Je-Yong Choi, Seong-Gon Kim
Förderung
- Rural Development of Administration, Republic of Korea
- Rural Development Administration, Republic of Korea
Zitieren
APA
Kim, J. Y., Che, X., Kim, S., Choi, J., Lee, J. H., Lee, J. H., Kweon, H., Lee, S. K., Choi, J. Y., & Kim, S. G. (2025). Sericin’s Potential in Osteoporosis Management: The Roles of L-Serine and D-Serine in Bone Metabolism Regulation. Nutrients. https://doi.org/10.3390/nu17030574
Vancouver
Kim JY, Che X, Kim S, Choi J, Lee JH, Lee JH, et al. Sericin’s Potential in Osteoporosis Management: The Roles of L-Serine and D-Serine in Bone Metabolism Regulation. Nutrients. 2025. doi:10.3390/nu17030574
BibTeX
@article{Kim2025,
author = {Kim, Jwa-Young and Che, Xiangguo and Kim, Shihyun and Choi, Jongho and Lee, Joon Ha and Lee, Ji-Hae and Kweon, HaeYong and Lee, Suk Keun and Choi, Je-Yong and Kim, Seong-Gon},
title = {Sericin’s Potential in Osteoporosis Management: The Roles of L-Serine and D-Serine in Bone Metabolism Regulation},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17030574}
}
EUVIMED